4//SEC Filing
Xenon Pharmaceuticals Inc. 4
Accession 0001171843-14-005697
$XENECIK 0001582313operating
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 9:20 PM ET
Size
5.5 KB
Accession
0001171843-14-005697
Insider Transaction Report
Form 4
Bridger Gary
EVP, Research & Development
Transactions
- Award
Stock Option (Right to Buy)
2014-11-21+5,144→ 5,144 totalExercise: $12.65Exp: 2024-11-20→ Common Shares (5,144 underlying)
Footnotes (1)
- [F1]1,284 options vest on November 21, 2014, with 428 options vesting on a monthly basis thereafter, for the next 8 months, on the last day of each month (ie, beginning on 30-Nov-2014 and continuing to 30-Jun-2015), with the remaining 436 options vesting on July 31, 2015.
Documents
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001582313
Filing Metadata
- Form type
- 4
- Filed
- Nov 24, 7:00 PM ET
- Accepted
- Nov 25, 9:20 PM ET
- Size
- 5.5 KB